248 related articles for article (PubMed ID: 29601662)
1. African-American men and prostate cancer-specific mortality: a competing risk analysis of a large institutional cohort, 1989-2015.
Williams VL; Awasthi S; Fink AK; Pow-Sang JM; Park JY; Gerke T; Yamoah K
Cancer Med; 2018 May; 7(5):2160-2171. PubMed ID: 29601662
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
3. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
[TBL] [Abstract][Full Text] [Related]
4. Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting.
Howard LE; Zhang J; Fishbane N; Hoedt AM; Klaassen Z; Spratt DE; Vidal AC; Lin D; Hitchins MP; You S; Freeman MR; Yamoah K; Davicioni E; Freedland SJ
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):419-428. PubMed ID: 31844180
[TBL] [Abstract][Full Text] [Related]
5. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
Mahal BA; Chen YW; Muralidhar V; Mahal AR; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Yu JB; Feng FY; Kim SP; Beard CJ; Martin NE; Trinh QD; Nguyen PL
Ann Oncol; 2017 May; 28(5):1098-1104. PubMed ID: 28453693
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer.
Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Choueiri TK; Hu JC; Hoffman KE; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Trinh QD; Nguyen PL
Clin Genitourin Cancer; 2014 Oct; 12(5):e189-95. PubMed ID: 24861952
[TBL] [Abstract][Full Text] [Related]
7. Income inequality and treatment of African American men with high-risk prostate cancer.
Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
[TBL] [Abstract][Full Text] [Related]
8. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
9. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.
Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Lago-Hernandez C; Choueiri TK; Elfiky AA; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Lathan CS; Trinh QD; Nguyen PL
J Geriatr Oncol; 2014 Oct; 5(4):352-8. PubMed ID: 24862107
[TBL] [Abstract][Full Text] [Related]
11. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.
Suresh T; Sharma J; Goel S; Kovac E; Gao Q; Gartrell B
Clin Genitourin Cancer; 2019 Apr; 17(2):139-144. PubMed ID: 30655076
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients.
Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Mazzone E; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2018 Aug; 1(3):215-222. PubMed ID: 31102624
[TBL] [Abstract][Full Text] [Related]
13. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.
Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Lathan C; Kim SP; Trinh QD; Nguyen PL
Urol Oncol; 2014 Nov; 32(8):1285-91. PubMed ID: 24846344
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE
Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088
[TBL] [Abstract][Full Text] [Related]
15. Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer.
Awasthi S; Berglund A; Abraham-Miranda J; Rounbehler RJ; Kensler K; Serna A; Vidal A; You S; Freeman MR; Davicioni E; Liu Y; Karnes RJ; Klein EA; Den RB; Trock BJ; Campbell JD; Einstein DJ; Gupta R; Balk S; Lal P; Park JY; Cleveland JL; Rebbeck TR; Freedland SJ; Yamoah K
Clin Cancer Res; 2021 Jan; 27(1):320-329. PubMed ID: 33037017
[TBL] [Abstract][Full Text] [Related]
16. Racial disparities in Black men with prostate cancer: A literature review.
Lillard JW; Moses KA; Mahal BA; George DJ
Cancer; 2022 Nov; 128(21):3787-3795. PubMed ID: 36066378
[TBL] [Abstract][Full Text] [Related]
17. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE
JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
[TBL] [Abstract][Full Text] [Related]
19. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
20. Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.
Hayn MH; Orom H; Shavers VL; Sanda MG; Glasgow M; Mohler JL; Underwood W
Cancer; 2011 Oct; 117(20):4651-8. PubMed ID: 21456009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]